• gmp-verlag.de
  • GMP Compliance Adviser Login
  • Shopping cart
Stay informed!

You’d like to be regularly informed on the latest developments in Good Manufacturing Practices?


Subscribe to our free GMP Newsletter LOGFILE!


2017 - The GMP Regulations Report

Have you considered all last years new regulations?

Make sure you did not miss out on one or the other with our overview of 24 important GMP documents published in 2017.

>>> Read now:

GMP Compliance Adviser

GMP in Practice: 24 chapters written by internationally renowned industry experts.


GMP Regulations: 8 chapters with the most important GMP guidelines and regulations.




Award for the
GMP Compliance Adviser

GMP knowledge that convinces.


On 7 June 2016 Maas & Peither GMP Publishing has received a

SIPAward in the category
"Best New Success Story" and was awarded with the 3rd place.

The GMP MANUAL (now: GMP Compliance Adviser) impressed the jury with "Safe Drugs through Better GMP Understanding".

TOP 5 GMP Downloads

1. Questionnaire for preparing GMP-inspections
More than 650 typical questions related to audits and inspections.

2. GMP Fundamentals
A quick and comprehensive overview of the complex world of GMP.

3. GDP Audit Questionnaire
More than 700 questions with reference to regulations.

4. A Pharma Guide to Cleaning Validation
How to meet Agency Expectations and Establish Accepted Limits.

5. Data Integrity in the EU
Requirements for Quality Management Systems.

>>> More Downloads

News about GMP/cGMP


Swissmedic publishes Annual Report 2016

According to the Swiss Therapeutic Products Agency Swissmedic, the agency achieved its objectives last year. Regulatory approval was granted for more than 40 innovative medicinal products partially due to a fast-track procedure.


An increase of 50% of new active substances for the Swiss market shows that the pharmaceutical industry in Switzerland in continuing to invest heavily in research and into the development of medicines.

The time taken to complete the approval procedure as a proportion of the total time from development to market launch is an important factor in the success of a new medicine.

Under certain circumstances medicinal products can be granted a marketing authorisation within 140 days provided that their quality, efficacy and safety are evaluated positively. Seven of the 42 applications for medicinal products with new active substances that were completed last year were processed using the accelerated approval procedure.

In the course of its oversight activities, Swissmedic coordinated the Swiss inspection system and conducted 65 of its own inspections in the reporting period. Together with the four regional inspectorates 619 manufacturers and wholesalers were inspected.

The Swissmedic inspectors monitored primarily establishments in the pharmaceutical industry and examined whether manufacturers of pharmaceutical products comply with the international quality standards of Good Manufacturing Practice. As regards wholesale companies, the focus was on the implementation of and compliance with the current European guidelines of Good Distribution Practice, which have been in force in Switzerland since January 2016.

In addition, Swissmedic agreed to intensify collaboration with two partner authorities abroad: two Memoranda of Understanding (MoU) were signed with the British MHRA (Medicinal and Health Products Regulatory Authority) and with COFEPRIS (Federal Commission for Protection against Sanitary Risk) in Mexico. In October the Agency also organised the annual meeting of the heads of medicinal and therapeutic product authorities. The summit in Interlaken was attended by some 75 representatives from 23 countries. This was the first time that it had been held in Switzerland.

No comment has yet been written about this news.
Literature recommendation
GMP Compliance Adviser
Single User Licence (yearly subscription)